Vascular closure devices are frequently used after percutaneous arterial interventions to achieve hemostasis at the puncture site and facilitate early ambulation. Occasionally, complications have been reported with closure devices, such as hematoma, infection, arteriovenous fistula, pseudoaneurysm, and ischemia. This is a report of 2 cases of severe, acute-onset arterial occlusion and critical limb ischemia, one of which occurred in the upper limb following the use of a vascular closure device, and the required surgical treatment.
INTRODUCTION
Vascular closure devices (VCDs) were specifically designed to provide faster hemostasis following arteriotomy. One of these devices, the Angio-Seal vascular closure device (St. Jude Medical, Inc., St. Paul, MN, USA), consists of a polymer anchor, a small bovine collagen sponge, and a traction suture; all components of the device are absorbed within 60 to 90 days. [1, 2] The device seals and compresses the arterial wall between the anchor and the collagen sponge. [3] VCDs have many advantages, such as immediate hemostasis, and early ambulation and hospital discharge. [1, 4] However, in terms of minor or major vascular complications, it is still controversial as to whether VCDs are more efficient than manual compression (MC). [4, 5] VCD-related complications have been reported, including access site infection and acute arterial occlusion that may require extra-surgical intervention. [2, 3] Herein, 2 cases of limb-threatening ischemic complications following the use of Angio-Seal vascular closure device are reported.
CASE REPORT
Case 1 -A 55-year-old woman experienced severe pain, pulselessness, and pallor in the right leg immediately after digital subtraction angiography to assess a coiled middle cerebral artery bifurcation aneurysm via femoral access that was closed with an Angio-Seal vascular closure device (St. Jude Medical, Inc., St. Paul, MN, USA). An hour after the procedure, there were no audible Doppler signals at the right ankle and aorto-ilio-femoral angiography demonstrated a thrombus in the distal right popliteal artery ( Fig. 1a,b ). After informed consent was obtained, the entire closure device, collagen sponge, and suture tail were located at the puncture site anterior to the common femoral artery and extracted from the lumen. A thrombectomy was performed ( Fig. 1c ), the patient was monitored in the intensive care unit, and later discharged from the hospital without any complication. At 1-month follow-up, the patient had no claudication or complaints. artery (SMA) occlusion was admitted with severe abdominal pain after eating. The patient underwent digital subtraction angiography to assess the SMA via a left axillary artery approach. An Angio-Seal vascular closure device was used for arterial closure. After the procedure, the patient developed sudden severe pain, pulselessness, pallor, and coolness in the left arm. Immediate arterial duplex scanning revealed an occlusion of the left axillary artery. After obtaining informed consent, an embolectomy was performed and the closure device was removed from the distal brachial artery with the collagen sponge and suture tail (Fig. 2) . The patient was discharged on postoperative day 2 without symptoms of claudication.
DISCUSSION
VCDs were developed in the early 1990s as a faster means to close arterial puncture areas than MC. [1, 2, 5, 6] Though recent meta-analyses have failed to demonstrate the clear superiority of VCDs to MC, their use in clinical practice is widely accepted, despite an increase in device-related complications. [4, 5, 7] MC requires an educated medical staff, manpower, prolonged bed rest, and long-time pressure on the puncture area. [1] [2] [3] 7] To overcome these disadvantages of compression, an alternative was found: closure devices. VCDs offer many advantages, such as immediate hemostasis, successful use in patients who are highly anticoagulated, and early ambulation and hospital discharge. [1, 4] On the other hand, these devices may lead to some complications, including hematoma, acute limb ischemia, and infection, which occur in up to 2.5% of patients. [5, 8] Nikolsky et al. [5] described in a meta-analysis that the risk of major or minor vascular complications was similar to that of MC. In another study of 7376 patients in whom the Angio-Seal VCD was applied, device-related symptomatic lower limb ischemia was found in 14 cases (0.2%). [9] The cause of these iatrogenic complications was not clear, but they may have been related to malpositioning of the device, intimal dissection, or significant atherosclerosis at the puncture site. [2, 3] The risk factors for limb-threatening ischemic complications following the use of a vascular closure device are diabetes, obesity, peripheral vascular disease with arterial wall calcification, and severe ischemic heart disease. [8, 11] Complication rates can be higher in women than in men due to the smaller arteries found in women. [11] There is no consensus on the treatment strategy for patients with ischemic complications. Device-related complications can be treated with interventional therapy, including balloon angioplasty, stent grafting, extraction with a snare catheter, and arterectomy. Repetitive surgical approaches may be unavoidable if an acute ischemic complication is present. [10] In Case 1, the device-related complication seems to have been related to distal embolization originating around the polymer anchor in a stenotic length of artery with or without an arterial wall lesion (Fig. 1a) . In Case 2, which occurred in the upper limb, intra-arterial deployment of the anchor led to displacement of the collagen plug in the small arterial lumen. When treating device-related complications, the special structure of the VCD should be kept in mind and therapeutic options must be reviewed.
Conclusion
The use of closure devices to provide immediate hemostasis in patients undergoing interventional procedures may enhance patient comfort and facilitate early ambulation; nevertheless, they can also result in significant life and limb-threatening ischemic complications. Thus, cardiologists, interventional radiologists, and vascular surgeons should be aware of rare, but serious, complications. The use of routine duplex scanning after the interventional procedure may be beneficial, especially in patients with comorbidities, such as diabetes, obesity, peripheral vascular disease, and severe ischemic heart disease. Moreover, careful assessment of the arterial wall structure before the use of VCDs may also play a pivotal role in avoiding complications.
Finally, and most importantly, close observation of patients following the use of a VCD is important and highly recommended in order not to overlook any acute complications, especially limb ischemia. 
